Protein–protein interactions as targets for small-molecule therapeutics in cancer

p53, the cellular gatekeeper for growth and division

Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693 · see citing works

In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2

Vassilev, L. T., Vu, B. T., Graves, B., Carvajal, D., Podlaski, F., Filipovic, Z., Kong, N., Kammlott, U., Lukacs, C., Klein, C., et al. (2004) · Science · doi:10.1126/science.1092472 · Cited by 4,661 · see citing works

Smac, a Mitochondrial Protein that Promotes Cytochrome c–Dependent Caspase Activation by Eliminating IAP Inhibition

Du, C., Fang, M., Li, Y., Li, L., & Wang, X. (2000) · Cell · doi:10.1016/s0092-8674(00)00008-8 · Cited by 3,513 · see citing works

An inhibitor of Bcl-2 family proteins induces regression of solid tumours

Oltersdorf, T., Elmore, S. W., Shoemaker, A. R., Armstrong, R. C., Augeri, D. J., Belli, B., Bruncko, M., Deckwerth, T. L., Dinges, J., Hajduk, P. J., et al. (2005) · Nature · doi:10.1038/nature03579 · Cited by 3,407 · see citing works

Identification of DIABLO, a Mammalian Protein that Promotes Apoptosis by Binding to and Antagonizing IAP Proteins

Verhagen, A. M., Ekert, P. G., Pakusch, M., Silke, J., Connolly, L. M., Reid, G. E., Moritz, R. L., Simpson, R. J., & Vaux, D. L. (2000) · Cell · doi:10.1016/s0092-8674(00)00009-x · Cited by 2,372 · see citing works

Thymocyte apoptosis induced by p53-dependent and independent pathways

Clarke, A. R., Purdie, C. A., Harrison, D. J., Morris, R. G., Bird, C. C., Hooper, M. L., & Wyllie, A. H. (1993) · Nature · doi:10.1038/362849a0 · Cited by 2,271 · see citing works

Structure of the MDM2 Oncoprotein Bound to the p53 Tumor Suppressor Transactivation Domain

Kussie, P. H., Gorina, S., Marechal, V., Elenbaas, B., Moreau, J., Levine, A. J., & Pavletich, N. P. (1996) · Science · doi:10.1126/science.274.5289.948 · Cited by 2,206 · see citing works

Anatomy of hot spots in protein interfaces

Bogan, A. A., & Thorn, K. S. (1998) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.1843 · Cited by 1,988 · see citing works

The atomic structure of protein-protein recognition sites 1 1Edited by A. R. Fersht

Conte, L. L., Chothia, C., & Janin, J. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.2439 · Cited by 1,967 · see citing works

Reaching for high-hanging fruit in drug discovery at protein–protein interfaces

Wells, J. A., & McClendon, C. L. (2007) · Nature · doi:10.1038/nature06526 · Cited by 1,963 · see citing works

The p53-mdm-2 autoregulatory feedback loop.

Wu, X., Bayle, J. H., Olson, D., & Levine, A. J. (1993) · Genes & Development · doi:10.1101/gad.7.7a.1126 · Cited by 1,801 · see citing works

Small-molecule inhibitors of protein–protein interactions: progressing towards the dream

Arkin, M. R., & Wells, J. A. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1343 · Cited by 1,705 · see citing works

Structure of Bcl-x _L -Bak Peptide Complex: Recognition Between Regulators of Apoptosis

Sattler, M., Liang, H., Nettesheim, D., Meadows, R. P., Harlan, J. E., Eberstadt, M., Yoon, H. S., Shuker, S. B., Chang, B. S., Minn, A. J., et al. (1997) · Science · doi:10.1126/science.275.5302.983 · Cited by 1,476 · see citing works

IAPs block apoptotic events induced by caspase‐8 and cytochrome c by direct inhibition of distinct caspases

Deveraux, Q. L., Roy, N., Stennicke, H. R., Arsdale, T. V., Zhou, Q., Srinivasula, S. M., Alnemri, E. S., Salvesen, G. S., & Reed, J. C. (1998) · The EMBO Journal · doi:10.1093/emboj/17.8.2215 · Cited by 1,390 · see citing works

Activation of Apoptosis in Vivo by a Hydrocarbon-Stapled BH3 Helix

Walensky, L. D., Kung, A. L., Escher, I., Malia, T. J., Barbuto, S., Wright, R. D., Wagner, G., Verdine, G. L., & Korsmeyer, S. J. (2004) · Science · doi:10.1126/science.1099191 · Cited by 1,349 · see citing works

IAP Antagonists Induce Autoubiquitination of c-IAPs, NF-κB Activation, and TNFα-Dependent Apoptosis

Varfolomeev, E., Blankenship, J. W., Wayson, S. M., Fedorova, A. V., Kayagaki, N., Garg, P., Zobel, K., Dynek, J. N., Elliott, L. O., Wallweber, H. J. A., et al. (2007) · Cell · doi:10.1016/j.cell.2007.10.030 · Cited by 1,218 · see citing works

Promoting apoptosis as a strategy for cancer drug discovery

Fesik, S. W. (2005) · Nature reviews. Cancer · doi:10.1038/nrc1736 · Cited by 1,095 · see citing works

Decision making by p53: life, death and cancer

Oren, M. (2003) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401183 · Cited by 1,063 · see citing works

IAP Antagonists Target cIAP1 to Induce TNFα-Dependent Apoptosis

Vince, J. E., Wong, W. W.-L., Khan, N. R., Feltham, R., Chau, D., Ahmed, A. U., Benetatos, C. A., Chunduru, S. K., Condon, S. M., McKinlay, M. A., et al. (2007) · Cell · doi:10.1016/j.cell.2007.10.037 · Cited by 1,061 · see citing works

Bcl-2 family proteins

Reed, J. C. (1998) · Oncogene · doi:10.1038/sj.onc.1202591 · Cited by 1,057 · see citing works

The inhibitors of apoptosis (IAPs) and their emerging role in cancer

LaCasse, E. C., Baird, S. D., Korneluk, R. G., & MacKenzie, A. (1998) · Oncogene · doi:10.1038/sj.onc.1202569 · Cited by 980 · see citing works

Death Signal-induced Localization of p53 Protein to Mitochondria

Marchenko, N. D., Zaika, A. I., & Moll, U. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.21.16202 · Cited by 902 · see citing works

A small molecule inhibitor of β-catenin/cyclic AMP response element-binding protein transcription

Emami, K. H., Nguyen, C., Ma, H., Kim, D. H., Jeong, K. W., Eguchi, M., Moon, R. T., Teo, J.-L., Oh, S. W., Kim, H. Y., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404875101 · Cited by 879 · see citing works

Database of p53 gene somatic mutations in human tumors and cell lines.

Hollstein, M. C., Rice, K., Greenblatt, M. S., Soussi, T., Fuchs, R., Sørlie, T., Hovig, E. J., Smith‐Sørensen, B., Montesano, R., & Harris, C. C. (1994) · Europe PMC (PubMed Central) · Cited by 860 · see citing works

Structural Basis for the Inhibition of Caspase-3 by XIAP

Riedl, S. J., Renatus, M., Schwarzenbacher, R., Zhou, Q., Sun, C. C., Fesik, S. W., Liddington, R., & Salvesen, G. S. (2001) · Cell · doi:10.1016/s0092-8674(01)00274-4 · Cited by 793 · see citing works

Mechanism of Action of Antitumor Drugs that Interact with Microtubules and Tubulin

Jordan, M. A. (2005) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1568011023354290 · Cited by 776 · see citing works

Differential induction of transcriptionally active p53 following UV or lonizing radiation: Defects in chromosome instability syndromes?

Lü, X. (1993) · Cell · doi:10.1016/0092-8674(93)90496-d · Cited by 772 · see citing works

Unraveling hot spots in binding interfaces: progress and challenges

DeLano, W. L. (2002) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(02)00283-x · Cited by 767 · see citing works

Small molecule RITA binds to p53, blocks p53–HDM-2 interaction and activates p53 function in tumors

Issaeva, N., Bozko, P. M., Enge, M., Protopopova, M., Verhoef, L. G. G. C., Masucci, M. G., Pramanik, A., & Selivanova, G. (2004) · Nature Medicine · doi:10.1038/nm1146 · Cited by 749 · see citing works

Mining the Wnt pathway for cancer therapeutics

Barker, N., & Clevers, H. C. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2154 · Cited by 746 · see citing works

Direct interaction of Ras and the amino-terminal region of Raf-1 in vitro

Warne, P. H., Vician, P. R., & Downward, J. (1993) · Nature · doi:10.1038/364352a0 · Cited by 729 · see citing works

The Bcl-2 protein family: sensors and checkpoints for life-or-death decisions

Borner, C. (2002) · Molecular Immunology · doi:10.1016/s0161-5890(02)00252-3 · Cited by 700 · see citing works

Epothilones, a new class of microtubule-stabilizing agents with a taxol-like mechanism of action.

Bollag, D. M., McQueney, P. A., Zhu, J., Hensens, O. D., Koupal, L. R., Liesch, J. M., Goetz, M., Lazarides, E., & Woods, C. M. (1995) · PubMed · Cited by 687 · see citing works

Tubulin as a target for anticancer drugs: Agents which interact with the mitotic spindle

Jordan, A. M., Hadfield, J. A., Lawrence, N. J., & McGown, A. T. (1998) · Medicinal Research Reviews · doi:10.1002/(sici)1098-1128(199807)18:4 · Cited by 671 · see citing works

Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3.

Wang, X. W., Forrester, K., Yeh, H., Feitelson, M. A., Gu, J., & Harris, C. C. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.6.2230 · Cited by 666 · see citing works

Twenty years of p53 research: structural and functional aspects of the p53 protein

May, P., & May, E. (1999) · Oncogene · doi:10.1038/sj.onc.1203285 · Cited by 663 · see citing works

Apoptosis-based therapies

Reed, J. C. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd726 · Cited by 640 · see citing works

Structural Basis of Caspase-7 Inhibition by XIAP

Chai, J., Shiozaki, E. N., Srinivasula, S. M., Wu, Q. Y., Dataa, P., Alnemri, E. S., & Shi, Y. (2001) · Cell · doi:10.1016/s0092-8674(01)00272-0 · Cited by 582 · see citing works

Functions of the MDM2 oncoprotein

Freedman, D. A., Wu, L., & Levine, A. J. (1999) · Cellular and Molecular Life Sciences · doi:10.1007/s000180050273 · Cited by 573 · see citing works

Autocrine TNFα Signaling Renders Human Cancer Cells Susceptible to Smac-Mimetic-Induced Apoptosis

Petersen, S. L., Wang, L., Yalcin-Chin, A., Li, L., Peyton, M., Minna, J. D., Harran, P. G., & Wang, X. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.08.029 · Cited by 572 · see citing works

The inhibitors of apoptosis (IAPs) as cancer targets

Hunter, A. M., LaCasse, E. C., & Korneluk, R. G. (2007) · Apoptosis · doi:10.1007/s10495-007-0087-3 · Cited by 565 · see citing works

Inhibitor of Apoptosis Proteins: Translating Basic Knowledge into Clinical Practice

Schimmer, A. D. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1918 · Cited by 513 · see citing works

Protein−Protein Interactions: Interface Structure, Binding Thermodynamics, and Mutational Analysis

Stites, W. E. (1997) · Chemical Reviews · doi:10.1021/cr960387h · Cited by 491 · see citing works

Structural Basis of Caspase Inhibition by XIAP

Huang, Y., Park, Y. C., Rich, R. L., Segal, D., Myszka, D. G., & Wu, H. (2001) · Cell · doi:10.1016/s0092-8674(01)00273-2 · Cited by 480 · see citing works

Strategies for Targeting Protein–Protein Interactions With Synthetic Agents

Yin, H. H., & Hamilton, A. D. (2005) · Angewandte Chemie International Edition · doi:10.1002/anie.200461786 · Cited by 453 · see citing works

Herceptin: mechanisms of action and resistance

Nahta, R., & Esteva, F. J. (2005) · Cancer Letters · doi:10.1016/j.canlet.2005.01.041 · Cited by 446 · see citing works

New approaches to molecular cancer therapeutics

Collins, I., & Workman, P. (2006) · Nature Chemical Biology · doi:10.1038/nchembio840 · Cited by 390 · see citing works

Structural Basis for the Interaction of Tubulin with Proteins and Drugs that Affect Microtubule Dynamics

Downing, K. H. (2000) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.16.1.89 · Cited by 383 · see citing works

Discodermolide, A Cytotoxic Marine Agent That Stabilizes Microtubules More Potently Than Taxol^,

ter Haar, E., Kowalski, R. J., Hamel, E., Lin, C. M., Longley, R. E., Gunasekera, S. P., Rosenkranz, H. S., & Day, B. W. (1996) · Biochemistry · doi:10.1021/bi9515127 · Cited by 382 · see citing works

Structural Insights into Microtubule Function

Nogales, E. (2001) · Annual Review of Biophysics and Biomolecular Structure · doi:10.1146/annurev.biophys.30.1.397 · Cited by 378 · see citing works

Discovery of Potent Antagonists of the Antiapoptotic Protein XIAP for the Treatment of Cancer

Oost, T. K., Sun, C. C., Armstrong, R. C., Al-Assaad, A.-S., Betz, S. F., Deckwerth, T. L., Ding, H., Elmore, S. W., Meadows, R. P., Olejniczak, E. T., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm040037k · Cited by 367 · see citing works

How the Bcl-2 family of proteins interact to regulate apoptosis

van Delft, M. F., & Huang, D. C. S. (2006) · Cell Research · doi:10.1038/sj.cr.7310028 · Cited by 335 · see citing works

Inhibition of Protein−Protein Association by Small Molecules: Approaches and Progress

Toogood, P. L. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm010468s · Cited by 281 · see citing works

Chalcone Derivatives Antagonize Interactions between the Human Oncoprotein MDM2 and p53

Stoll, R., Renner, C., Hansen, S., Palme, S., Klein, C., Belling, A., Żesławski, W., Kamionka, M., Rehm, T., Mühlhahn, P., et al. (2000) · Biochemistry · doi:10.1021/bi000930v · Cited by 275 · see citing works

Apoptosis regulators and their role in tumorigenesis

Zörnig, M., Hueber, A., Baum, W., & Evan, G. I. (2001) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(01)00031-2 · Cited by 239 · see citing works

Structural basis for specificity of GRB2-SH2 revealed by a novel ligand binding mode

Rahuel, J., Gay, B., Erdmann, D., et al. (1996) · Nature Structural Biology · doi:10.1038/nsb0796-586 · Cited by 236 · see citing works

Structural Basis of Caspase Inhibition by XIAP Differential Roles of the Linker versus the BIR Domain

Huang, Y. (2001) · Cell · doi:10.1016/s0092-8674(02)02075-5 · Cited by 233 · see citing works

An Antagonist of Dishevelled Protein-Protein Interaction Suppresses β-Catenin–Dependent Tumor Cell Growth

Fujii, N., You, L., Xu, Z., Uematsu, K., Shan, J., He, B., Mikami, I., Edmondson, L. R., Neale, G. A. M., Zheng, J., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2726 · Cited by 232 · see citing works

Eleutherobin, a novel cytotoxic agent that induces tubulin polymerization, is similar to paclitaxel (Taxol).

Long, B. H., Carboni, J. M., Wasserman, A. J., et al. (1998) · PubMed · Cited by 222 · see citing works

Therapeutic Effect of a Retroviral Wild-Type p53 Expression Vector in an Orthotopic Lung Cancer Model

Fujiwara, T., Cai, D. W., Georges, R. N., et al. (1994) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/86.19.1458 · Cited by 220 · see citing works

Exploring Protein–Protein Interactions with Phage Display

Sidhu, S. S., Fairbrother, W. J., & Deshayes, K. (2003) · ChemBioChem · doi:10.1002/cbic.200390008 · Cited by 189 · see citing works

Protein–protein interactions and cancer: small molecules going in for the kill

Arkin, M. R. (2005) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2005.03.001 · Cited by 176 · see citing works

p53 Activation by Small Molecules: Application in Oncology

Vassilev, L. T. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm058174k · Cited by 172 · see citing works

Isolation and Structure Elucidation of Chlorofusin, a Novel p53-MDM2 Antagonist from a Fusarium sp.

Duncan, S. J., Grüschow, S., Williams, D. H., McNicholas, C., Purewal, R., Hájek, M., Gerlitz, M., Martin, S., Wrigley, S. K., & Moore, M. (2001) · Journal of the American Chemical Society · doi:10.1021/ja002940p · Cited by 171 · see citing works

Cell permeable Bcl-2 binding peptides: a chemical approach to apoptosis induction in tumor cells.

Wang, J., Zhang, Z. J., Choksi, S., et al. (2000) · PubMed · Cited by 168 · see citing works

Localization of the Vinblastine-binding Site on β-Tubulin

Rai, S. S., & Wolff, J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.25.14707 · Cited by 166 · see citing works

Localization of the colchicine-binding site of tubulin.

Uppuluri, S., Knipling, L., Sackett, D. L., et al. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.24.11598 · Cited by 161 · see citing works

Identification of Cysteine 354 of β-Tubulin as Part of the Binding Site for the A Ring of Colchicine

Bai, R., Pei, X., Boyé, O., et al. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.21.12639 · Cited by 159 · see citing works

Targeting protein–protein interactions for cancer therapy

Fry, D. C., & Vassilev, L. T. (2005) · Journal of Molecular Medicine · doi:10.1007/s00109-005-0705-x · Cited by 156 · see citing works

Anticancer therapy with novel tubulin-interacting drugs

Kavallaris, M., Verrills, N. M., & Hill, B. T. (2001) · Drug Resistance Updates · doi:10.1054/drup.2002.0230 · Cited by 129 · see citing works

Drugs Targeting Protein–Protein Interactions

Chêne, P. (2006) · ChemMedChem · doi:10.1002/cmdc.200600004 · Cited by 129 · see citing works

Targeting Ras and Rho GTPases as opportunities for cancer therapeutics

Walker, K. M., & Olson, M. F. (2004) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2004.11.001 · Cited by 125 · see citing works

NMR indicates that the small molecule RITA does not block p53-MDM2 binding in vitro

Krajewski, M., Ozdowy, P., D’Silva, L., Rothweiler, U., & Holak, T. A. (2005) · Nature Medicine · doi:10.1038/nm1105-1135 · Cited by 96 · see citing works

Modulation of Protein-Protein Interactions by Stabilizing/Mimicking Protein Secondary Structure Elements

de Vega, M. J. P., Martín‐Martinez, M., & González‐Muñiz, R. (2006) · Current Topics in Medicinal Chemistry · doi:10.2174/156802607779318325 · Cited by 90 · see citing works

Restoration of wild‐type p53 function in human cancer: Relevance for tumor therapy

Bossi, G., & Sacchi, A. (2007) · Head & Neck · doi:10.1002/hed.20529 · Cited by 87 · see citing works

Computational Identification of Inhibitors of Protein-Protein Interactions

Zhong, S., Macias, A. T., & MacKerell, A. D. (2006) · Current Topics in Medicinal Chemistry · doi:10.2174/156802607779318334 · Cited by 84 · see citing works

Structure-Based Design and Synthesis of High Affinity Tripeptide Ligands of the Grb2-SH2 Domain

Furet, P., Gay, B., Caravatti, G., Garcı́a-Echeverrı́a, C., Rahuel, J., Schoepfer, J. G., & Fretz, H. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm980159a · Cited by 83 · see citing works

Sulindac‐Derived Ras Pathway Inhibitors Target the Ras–Raf Interaction and Downstream Effectors in the Ras Pathway

Waldmann, H., Karaguni, I., Carpintero, M., Gourzoulidou, E., Herrmann, C., Brockmann, C., Oschkinat, H., & Müller, O. (2004) · Angewandte Chemie International Edition · doi:10.1002/anie.200353089 · Cited by 83 · see citing works

SH2 domain inhibition: a problem solved?

Shakespeare, W. C. (2001) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(00)00222-2 · Cited by 82 · see citing works

Luxury accommodations: the expanding role of structural plasticity in protein–protein interactions

Sundberg, E. J., & Mariuzza, R. A. (2000) · Structure · doi:10.1016/s0969-2126(00)00167-2 · Cited by 81 · see citing works

Inhibiting transient protein–protein interactions: lessons from the Cdc25 protein tyrosine phosphatases

Rudolph, J. (2007) · Nature reviews. Cancer · doi:10.1038/nrc2087 · Cited by 79 · see citing works

Dangerous habits of a security guard: the two faces of p53 as a drug target

Gudkov, A. V., & Komarova, E. A. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm052 · Cited by 67 · see citing works

New insights into microtubule structure and function from the atomic model of tubulin

Downing, K. H., & Nogales, E. (1998) · European Biophysics Journal · doi:10.1007/s002490050153 · Cited by 66 · see citing works

Antimicrotubular drugs binding to vinca domain of tubulin

Gupta, S., & Bhattacharyya, B. (2003) · Molecular and Cellular Biochemistry · doi:10.1023/a:1026045100219 · Cited by 64 · see citing works

Inhibition of Grb2 SH2 Domain Binding by Non-Phosphate-Containing Ligands. 2. 4-(2-Malonyl)phenylalanine as a Potent Phosphotyrosyl Mimetic

Gao, Y., Luo, J. H., Yao, Z.-J., et al. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm9904248 · Cited by 57 · see citing works

NEGATIVELY STAINED VINBLASTINE AGGREGATES

Erickson, H. (1975) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1975.tb19191.x · Cited by 43 · see citing works

Potential Disease Targets for Drugs that Disrupt Protein - Protein Interactions of Grb2 and Crk Family Adaptors

Feller, S. M., & Lewitzky, M. (2006) · Current Pharmaceutical Design · doi:10.2174/138161206775474369 · Cited by 42 · see citing works

Macrocyclization in the Design of Grb2 SH2 Domain-Binding Ligands Exhibiting High Potency in Whole-Cell Systems

Wei, C.-Q., Gao, Y., Lee, K., Guo, R., Li, B., Zhang, M., Yang, D., & Burke, T. R. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm0203635 · Cited by 41 · see citing works

Protein-Protein Interactions: Lessons Learned

Sharma, S., Ramsey, T. M., & Bair, K. W. (2002) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1568011023354191 · Cited by 37 · see citing works

Recent advances in understanding apoptosis: new therapeutic opportunities in cancer chemotherapy

Makin, G., & Dive, C. (2003) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(03)00084-4 · Cited by 35 · see citing works

Macrocyclization in the design of a conformationally constrained Grb2 SH2 domain inhibitor

Gao, Y., Voigt, J. H., Wu, J. X., et al. (2001) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(01)00316-x · Cited by 34 · see citing works

Functions of the p53 Protein in Growth Regulation and Tumor SuppressionPreprint

Lin, J., Wu, X., Chen, J., Chang, A., & Levine, A. J. (1994) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.1994.059.01.026 · Cited by 32 · see citing works

Induction of apoptosis by transiently transfected metabolically stable wt p53 in transformed cell lines.

Yonish-Rouach, E., Borde, J., Gotteland, M., Mishal, Z., Viron, A., & May, E. (1994) · PubMed · Cited by 30 · see citing works

Expression of exogenous wt-p53 does not affect normal hematopoiesis: implications for bone marrow purging

Scardigli, R., Bossi, G., Blandino, G., et al. (1997) · Gene Therapy · doi:10.1038/sj.gt.3300530 · Cited by 21 · see citing works

Small Molecule Inhibitors of the XIAP Protein-Protein Interaction

Rajapakse, H. A. (2007) · Current Topics in Medicinal Chemistry · doi:10.2174/156802607780906816 · Cited by 20 · see citing works

Reply to 'NMR indicates that the small molecule RITA does not block p53-MDM2 binding in vitro'

Grinkevich, V. V., Issaeva, N., Hossain, S., et al. (2005) · Nature Medicine · doi:10.1038/nm1105-1136 · Cited by 12 · see citing works

Drugs Targeting Protein–Protein Interactions

Chêne, P. (2007) · Chemical biology · doi:10.1002/9783527619375.ch15e · Cited by 12 · see citing works

Editorial [Hot Topic: Small Molecule Inhibition of Protein-Protein Interaction:An Emerging Paradigm in Drug Design (Guest Editor: Craig W. Lindsley)]

Lindsley, C. W. (2007) · Current Topics in Medicinal Chemistry · doi:10.2174/156802607780906780 · Cited by 2 · see citing works

Cellular senescence and cancer

(1999) · doi:10.1002/(sici)1096-9896(199901)187:1

Recent advances in the development of protein–protein interactions modulators: mechanisms and clinical trials

Lu, H., Zhou, Q., He, J., Jiang, Z., Peng, C., Tong, R., & Shi, J. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00315-3 · Cited by 891 · see citing works

Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials

Xie, X., Yu, T., Li, X., Zhang, N., Foster, L. J., Peng, C., Huang, W., & He, G. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01589-z · Cited by 396 · see citing works

Targeting protein–protein interactions in hematologic malignancies: still a challenge or a great opportunity for future therapies?

Cierpicki, T., & Grembecka, J. (2015) · Immunological Reviews · doi:10.1111/imr.12244 · Cited by 53 · see citing works

Antibody-enabled small-molecule drug discovery

Lawson, A. D. G. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3756 · Cited by 80 · see citing works

RNA‐Selective Small‐Molecule Ligands: Recent Advances in Live‐Cell Imaging and Drug Discovery

Chan, K. H., Wang, Y., Zheng, B., et al. (2023) · ChemMedChem · doi:10.1002/cmdc.202300271 · Cited by 10 · see citing works

Current Status and Strategy of Middle-Molecule Drug Discovery

Hidenori, M. (2022) · Proceedings for Annual Meeting of The Japanese Pharmacological Society · doi:10.1254/jpssuppl.95.0_2-s23-3

Target-Oriented and Diversity-Oriented Organic Synthesis in Drug Discovery

Schreiber, S. L. (2000) · Science · doi:10.1126/science.287.5460.1964 · Cited by 2,571 · see citing works

Design of Tracers in Fluorescence Polarization Assay for Extensive Application in Small Molecule Drug Discovery

Hua, L., Wang, D., Wang, K., Wang, Y., Gu, J., Zhang, Q., You, Q., & Wang, L. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c00881 · Cited by 33 · see citing works